PRECOSE
LOE ApproachingNDAORALTABLET
Approved
Sep 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PRECOSE by Bayer is mechanism of action: in contrast to sulfonylureas, precose does not enhance insulin secretion. First approved in 1995.
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRECOSE (acarbose) is an oral small-molecule alpha-glucosidase inhibitor approved in 1995 for type 2 diabetes management. It works by slowing glucose absorption in the small intestine, reducing postprandial (after-meal) blood sugar spikes without stimulating insulin secretion. It is commonly used as monotherapy or in combination with sulfonylureas, metformin, or insulin.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), indicating a mature, stable market with limited growth opportunity and likely smaller commercial teams.
Mechanism of Action
Mechanism of Action: In contrast to sulfonylureas, PRECOSE does not enhance insulin secretion. The antihyperglycemic action of acarbose results from a competitive, reversible inhibition of pancreatic alpha-amylase and membrane-bound intestinal alpha-glucoside hydrolase enzymes. Pancreatic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PRECOSE offers limited career growth opportunity given approaching loss of exclusivity, minimal clinical development, and competition from superior alternatives; roles focus on defending mature market share and cost management. This assignment is best suited for professionals seeking stability in a legacy product or gaining foundational pharma experience rather than high-growth advancement.
Worked on PRECOSE at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.